🇺🇸 FDA
Pipeline program

Cesium-131 brachytherapy

20-542

Phase 2 other active

Quick answer

Cesium-131 brachytherapy for Recurrent Brain Metastases is a Phase 2 program (other) at GT Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
GT Biopharma
Indication
Recurrent Brain Metastases
Phase
Phase 2
Modality
other
Status
active

Clinical trials